tradingkey.logo
tradingkey.logo
Search

TradingKey

15481 Articles

TradingKey is a comprehensive financial education and news analysis website, providing real-time market data, financial news coverage across forex, commodities, cryptocurrencies and more, as well as professional trading courses.

Palladium (XPDUSD) Drops on Oct 7: What Lie behind the Move?

• Weakening industrial demand and EV adoption drive palladium spot prices down. • High bond yields and a firm US dollar increase holding costs. • Stable global production keeps markets well-supplied, limiting immediate price support.
2 hours ago

USD/MXN (USDMXN) Surges 0.52% on Oct 7: What You Need to Watch

• USDMXN rose due to surging US dollar demand and narrowing yield differentials. • Institutional investors unwound carry-trade positions, exerting upward pressure on the currency pair. • Technical indicators show a MACD buy signal and a Williams %R buy condition.
3 hours ago

EUR/USD (EURUSD) Is down 0.58% on Oct 7: Why It Happened

• Fiscal anxiety and political fragmentation generated substantial selling pressure on the euro. • Rising crude oil prices eroded the euro's fundamental standing against the dollar. • Widening real interest rate differentials reinforced broad-based demand for the US dollar.
3 hours ago

Natural Gas - Futures (NATGAS-F) Is up 2.06% on Oct 7: Is the Market Repricing It?

• Natural gas futures advanced due to domestic production curtailments and higher export demand. • Modest storage injections steadily eroded the historical working gas surplus relative to averages. • Technical indicators showed a MACD buy signal and a neutral RSI reading.
3 hours ago

Natural Gas (NATGAS) Surges on Oct 7: What Lie behind the Move?

• Natural gas prices rose due to production curtailments and recovering export feedgas flows. • Consecutive below-average storage injections tightened working gas availability ahead of the winter season. • Technical indicators including MACD and Williams %R currently suggest a buy condition.
4 hours ago

Nurix Enrolls First Patient in Phase 1b/2 Bexobrutideg Combination Study

Nurix Therapeutics enrolled the first patient in a Phase 1b/2 study of bexobrutideg plus venetoclax for CLL/SLL under its Roche collaboration.
6 hours ago

Can Intel Challenge TSMC? Opportunities and Risks Behind 18A Mass Production

TradingKey - Against the backdrop of TSMC's long-standing dominance in the advanced process market, Intel (INTC) is attempting to return to the center of competition through Intel 18A.
7 hours ago

BNB (BNBUSD) Is down 1.98% on Oct 7: What Do On-Chain Data and Market Sentiment Show?

• BNB faced profit-taking after failing to break the crucial $800 resistance level. • Derivatives liquidation and macroeconomic headwinds added downside pressure and suppressed token momentum. • Technical indicators show neutral signals alongside an oversold Williams %R reading.
9 hours ago

Ethereum (ETHUSD) Is down 3.13% on Oct 7: Key Drivers to Watch

• U.S. spot Ethereum ETFs experienced sustained institutional capital outflows and net redemptions. • Firming U.S. Treasury yields and tightening macroeconomic conditions pressured digital asset demand. • Derivatives liquidation sweeps and bearish technical indicators amplified downward price volatility.
9 hours ago

XRP (XRPUSD) Fluctuated Significantly on Oct 7: Key Variables Behind the Move

• XRP pulled back due to profit-taking and cautious macroeconomic conditions. • Technical resistance and derivatives liquidations reinforced the recent price decline. • Neutral momentum indicators suggest XRP will remain in a consolidation phase.
9 hours ago

Nvidia vs. AMD: Which AI Chip Leader Is the Better Long-Term Investment?

TradingKey - As generative AI, AI agents, and data center investments continue to grow, Nvidia (NVDA) and AMD (AMD) remain the two most closely watched companies in the US AI chip sector.
9 hours ago

Solana (SOLUSD) Is down 1.11% on Oct 7: Why It Happened

• Digital asset markets consolidated ahead of macroeconomic catalysts and Federal Reserve policy minutes. • Solana experienced profit-taking following its new institutional settlement framework and reduced leverage. • Technical indicators show mixed signals with neutral MACD, neutral RSI, and buy Williams %R.
9 hours ago

Penguin Solutions Q4 Revenue Jumps 68%, FY2027 Outlook Raised

Penguin Solutions reported record Q4 FY2026 revenue of $567 million, driven by integrated memory and AI infrastructure, and raised its FY2027 outlook.
10 hours ago

RPM Posts Record Q1 Revenue, Sees Mid-Single-Digit FY2027 Growth

RPM reported record fiscal Q1 2027 revenue and adjusted EBITDA as Performance Coatings and Consumer growth offset Construction Products weakness, while inflation expectations increased.
11 hours ago

Lamb Weston Raises FY2027 Outlook After North America Volume Growth

Lamb Weston raised its fiscal 2027 outlook after North America volume growth supported first-quarter sales, offsetting weaker international results.
11 hours ago

Apogee Raises FY2027 Outlook as Q2 Sales Rise Across All Segments

Apogee Enterprises raised its fiscal 2027 sales and adjusted EPS guidance after second-quarter revenue rose 9.2%, with growth across all four segments.
11 hours ago

US Midterm Elections Approach: Here Is Why They Could Impact US Stocks

The 2026 U.S. midterm elections will take place on November 3, with all seats in the House of Representatives and a portion of the Senate up for election. According to CNBC, citing data from polling tracker FiftyPlusOne, Democrats hold a lead of about 6 percentage points in the generic House ballot and need a net gain of just 3 seats to retake control of the House, ending full Republican control of Congress.
11 hours ago

Penguin Solutions (PENG) Fiscal Q4 2026 Earnings Call: AI Growth Drives Record Sales

Penguin Solutions’ fiscal Q4 2026 sales rose 68% to $567 million as AI infrastructure and memory surged. Management targets 40% growth in fiscal 2027.
11 hours ago

Neogen (NEOG) Fiscal Q1 2027 Earnings Call: Guidance Raised on 8.1% Core Growth

Neogen’s fiscal Q1 2027 revenue rose 8.1% on a core basis to $222.8 million as management raised full-year revenue and adjusted EBITDA guidance.
11 hours ago

AXIL Fiscal Q1 2027 Earnings: XCOR II Transition Weighs on Revenue

AXIL’s fiscal Q1 2027 revenue fell 11.2% to $6.09 million as the company transitioned from XCOR to XCOR II and did not repeat a prior-year big-box order. Diluted EPS increased to $0.05 from $0.04, while reported gross margin rose to 82.6%, including a non-recurring $0.55 million customs-duty refund; excluding it, margin was approximately 73.6%. Operating cash flow swung to a $3.76 million inflow from a $0.74 million outflow. Initial XCOR II orders reached $3.6 million by September 30, with shipments underway in fiscal Q2.
15 hours ago
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.